2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Prostatic Neoplasms
14
Neoplasms
8
Breast Neoplasms
5
Hypogonadism
3
Eunuchism
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Obesity
2
Metabolic Syndrome
2
Fatigue
2
Dyspareunia
2
Arthralgia
2
Vaginitis
1
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Osteoporosis
1
Non-alcoholic Fatty Liver Disease
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Diseases
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hot Flashes
1
Diabetes Mellitus
1
Interventions
fludarabine
2
Metformin
2
Busulfan
2
thymoglobulin
1
fludarabine phosphate
1
bicalutamide
1
Testosterone
1
Saline Solution
1
Powders
1
Nutrition Assessment
1
Mesna
1
Melphalan
1
Magnetic Resonance Imaging
1
Influenza Vaccines
1
Honey
1
Heparin
1
Gonadotropin-Releasing Hormone
1
Gastric Bypass
1
Exercise
1
Eating
1
Cyclophosphamide
1
Clofarabine
1
Caloric Restriction
1
Antineoplastic Agents
1
Antilymphocyte Serum
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Diseases
×
Testosterone
×
Clear all
NCT05773183
2023-03-17
MMetdMH
Royal College of Surgeons, Ireland
Unknown
60 enrolled